What is Veru Inc. (VERU)?
Veru Inc. is a biopharmaceutical company engaged in the development and commercialization of therapeutics and diagnostics primarily for oncology and urology indications. The company focuses on addressing unmet medical needs through innovative drug candidates and diagnostic tools. Its product portfolio includes treatments for prostate cancer, breast cancer, and other diseases, with an emphasis on improving patient outcomes. Veru operates research and development programs aimed at advancing its pipeline of pharmaceutical products. The company also markets commercial products related to men's and women's health. Veru's activities encompass clinical development, regulatory affairs, and strategic partnerships to support its growth in the healthcare sector.
Veru Inc. Stock Price Today: Live Overview
The price today is shaped by ongoing market trades for Veru Inc., which is priced at $2.32. Its intraday range extends from $2.23 to $2.3, with a daily change of -0.4367%.
FAQ: Veru Inc. (VERU)
What is the current price of VERU stock?
The stock is currently priced at $2.32.
Does VERU pay dividends?
Veru Inc. does not pay dividends.
Does VERU have a formal corporate presence or regional headquarters in the UAE?
Veru Inc. operates in the UAE exclusively through partners and distributors without a direct regional office.
What is VERU best known for?
Veru Inc. is most famous for its pharmaceutical products targeting prostate cancer and breast cancer treatments.
What assets are typically shown together with VERU?
Commonly shown alongside VERU: Koninklijke Philips, Crinetics Pharmaceuticals Inc, EMCOR Group Inc
Latest shares articles



